NR4A1 and breast cancer: A later analysis within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort showed a positive association of breast cancer cases expressing ERα, classically referred to as hormone-receptor (HR)-positive breast cancer, with higher estrogen and androgen serum levels in postmenopausal women [16].